Multigene panel analysis in breast and ovarian cancer

被引:0
|
作者
Trapp, Elisabeth Katharina [1 ]
Speicher, Michael [2 ]
Geigl, Jochen B. [2 ]
Kolovetsiou-Kreiner, Vassiliki [1 ]
Reisinger, Julia [1 ]
Haas, Josef [1 ]
Petru, Edgar [1 ]
Tamussino, Karl [1 ]
Pristauz, Gunda [1 ]
机构
[1] Med Univ Graz, Dept Gynecol & Obstet, Graz, Austria
[2] Med Univ Graz, Dept Genet, Graz, Austria
关键词
D O I
10.1158/1538-7445.SABCS19-P5-03-09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5-03-09
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Jordan Lerner-Ellis
    Chloe Mighton
    Conxi Lazaro
    Nicholas Watkins
    Vanessa Di Gioacchino
    Andrew Wong
    Martin C. Chang
    George S. Charames
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 871 - 879
  • [2] Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Lerner-Ellis, Jordan
    Mighton, Chloe
    Lazaro, Conxi
    Watkins, Nicholas
    Di Gioacchino, Vanessa
    Wong, Andrew
    Chang, Martin C.
    Charames, George S.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (03) : 871 - 879
  • [3] Economic impact of multigene panel testing for hereditary breast and ovarian cancer
    Byfield, Stacey Dacosta
    Wei, Helen
    DuCharme, Mary
    Lancaster, Johnathan M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (03) : 207 - 217
  • [4] Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
    Ryu, Jin-Sun
    Lee, Hye-Young
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Kim, Min-Kyeong
    Joo, Jungnam
    Lee, Eun-Sook
    Kang, Han-Sung
    Lee, Seeyoun
    Lee, Dong Ock
    Lim, Myong Cheol
    Kong, Sun-Young
    CANCER SCIENCE, 2020, 111 (10) : 3912 - 3925
  • [5] The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition
    Moretta, Jessica
    Berthet, Pascaline
    Bonadona, Valerie
    Caron, Olivier
    Cohen-Haguenauer, Odile
    Colas, Chrystelle
    Corsini, Carole
    Cusin, Veronica
    De Pauw, Antoine
    Delnatte, Capucine
    Dussart, Sophie
    Jamain, Christophe
    Longy, Michel
    Luporsi, Elisabeth
    Maugard, Christine
    Tan Dat Nguyen
    Pujol, Pascal
    Vaur, Dominique
    Andrieu, Nadine
    Lasset, Christine
    Nogues, Catherine
    BULLETIN DU CANCER, 2018, 105 (10) : 907 - 917
  • [6] Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer
    Hirotsu, Yosuke
    Nakagomi, Hiroshi
    Sakamoto, Ikuko
    Amemiya, Kenji
    Oyama, Toshio
    Mochizuki, Hitoshi
    Omata, Masao
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2015, 3 (05): : 459 - 466
  • [7] Correction to: Multigene panel testing for hereditary breast and ovarian cancer in the province of Ontario
    Jordan Lerner-Ellis
    Chloe Mighton
    Conxi Lazaro
    Nicholas Watkins
    Vanessa Di Gioacchino
    Andrew Wong
    Martin C. Chang
    George S. Charames
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2487 - 2487
  • [8] Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
    Rossella Graffeo
    Luca Livraghi
    Olivia Pagani
    Aron Goldhirsch
    Ann H. Partridge
    Judy E. Garber
    Breast Cancer Research and Treatment, 2016, 160 : 393 - 410
  • [9] Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
    Desmond, Andrea
    Kurian, AllisonW.
    Gabree, Michele
    Mills, Meredith A.
    Anderson, Michael J.
    Kobayashi, Yuya
    Horick, Nora
    Yang, Shan
    Shannon, Kristen M.
    Tung, Nadine
    Ford, JamesM.
    Lincoln, Stephen E.
    Ellisen, Leifw.
    JAMA ONCOLOGY, 2015, 1 (07) : 943 - 951
  • [10] Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
    Graffeo, Rossella
    Livraghi, Luca
    Pagani, Olivia
    Goldhirsch, Aron
    Partridge, Ann H.
    Garber, Judy E.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 393 - 410